Ventavis (iloprost) 10 micrograms/2 mL nebuliser solution, 30 ampoules (Bayer Pharma) Treatment of pulmonary hypertension. Drug delivery from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Display.

• Treatment of patients with primary pulmonary hypertension and secondary pulmonary hypertension of moderate or severe stage, caused by diseases of tissues or caused by medicinal means.

• Treatment of patients with moderate or severe secondary hypertension caused by chronic inoperable thromboembolism. arteries.

• Ventavis is used for inhalation treatment.  

  Ready to administer before drying using other types of inhalation devices (inhalers) in accordance with the recommendations provided by the department “Insertion before drying”. It is possible to continue prior therapy or continue it depending on the needs of a particular patient (section “Interactions with other medicinal agents and other types of interactions”).  

  • Adult patients

  The recommended dose is 2.5 mcg or 5 mcg of inhaled iloprost (which corresponds to the dose of medicine in the inhaler tube). The treatment begins with a low dose, which is 2.5 mcg for the first inhalation, and moves up to a dose of 5 mcg for the next inhalation. In case of poor tolerance, the dose of 5 mcg should be reduced to 2.5 mcg.  

  The dose, which is indicated by a series of inhalations, must be administered 6 - 9 times a day depending on the needs and skin tolerance of the individual patient.

  It is important to ensure that the required dose in the tube and bottle of the inhaler ensures that the dryness of the skin series of inhalations becomes approximately 5 - 10 minutes.